Viridian Therapeutics Market Cap

Viridian Therapeutics has a market cap or net worth of €2.61 billion as of January 9, 2026. Its market cap has increased by 73.84% in one year.

Market Cap

2.61B

Enterprise Value

2.37B

Revenue

60.33M

Ranking

n/a

PE Ratio

n/a

Stock Price

€25.66

Market Cap Chart

Since February 14, 2017, Viridian Therapeutics's market cap has increased from 162.74M to 2.61B, an increase of 1,500.76%. That is a compound annual growth rate of 36.53%.

Market Cap History

Date	Market Cap	% Change
Jan 9, 2026	2.61B	2.98%
Dec 31, 2025	2.53B	72.47%
Dec 31, 2024	1.47B	41.55%
Dec 29, 2023	1.04B	-5.81%
Dec 30, 2022	1.10B	191.32%
Dec 31, 2021	377.62M	618.50%
Dec 31, 2020	Upgrade Pro	Upgrade Pro
Dec 31, 2019	Upgrade Pro	Upgrade Pro
Dec 31, 2018	Upgrade Pro	Upgrade Pro
Dec 29, 2017	Upgrade Pro	Upgrade Pro
Feb 14, 2017	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
SAP SE	247.30B
Siemens Aktiengesellschaft	197.59B
Allianz SE	145.37B
Deutsche Telekom AG	134.99B
Siemens Energy AG	107.65B
Rheinmetall AG	87.17B
Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München	67.47B
Deutsche Bank Aktiengesellschaft	63.02B

Market Cap Rankings